Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Injury incidence in NCAA men's sports during 2019/20-2021/22: findings from the injury surveillance program during the COVID-19 pandemic.

Created on 22 Sep 2026

Authors

Kody R Campbell, Adrian J Boltz, Neel Rao, Hannah Powers, William Felix, Aishwarya Bandaru, Christy L Collins, Avinash Chandran

Published in

Research in sports medicine (Print). Pages 1-18. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

National Collegiate Athletic Association (NCAA) men's sports feature elite athletes, and systematic injury surveillance efforts are required to inform injury risk mitigation strategies in this population. We describe the epidemiology of injuries in this population during the COVID-19-impacted 2019/20-2021/22 academic years. We examined inju distributions by sport, event type, body part, diagnosis, and mechanism of injury, and used a Bayesian negative binomial modelling framework to estimate injury incidence rates (per 1,000 athlete-exposures [AEs]). A total of 21,195 injuries were reported across the study period, with 24.7% of all injuries attributed to the lower leg/foot and 26.2% classified as sprains. The posterior mean overall injury rate was 7.6 per 1,000 AEs (95% Credible Interval: 6.9-8.4) and overall injury incidence was estimated to be highest in football. The patterns observed underscored that injury incidence in NCAA men's sports remain linked to the specific gameplay dynamics of each sport.

PMID:
42766444
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 43
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement